Hypertryptasemia and Mast Cell-Related Disorders in Severe Osteoporotic Patients.

Giulia CarosiGregorio GuabelloMatteo LonghiFederica GrifoniElena PasseriSabrina Corbetta

Published in: Mediators of inflammation (2020)

The prevalence of MC-related disorders in severe OP was 3.0%, accounting for the 7.4% of the secondary causes of OP. MC-related disorders may be involved in bone fragility and assessment of serum tryptase is useful to detect MC-related disorders.

Keyphrases

end stage renal disease
bone mineral density
newly diagnosed
early onset
peritoneal dialysis
prognostic factors
risk factors